Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression

  • Howard R. Weeks III,
  • Scott C. Tadler,
  • Kelly W. Smith,
  • Eli Iacob,
  • Mikala Saccoman,
  • Andrea T. White,
  • Joshua D. Landvatter,
  • Gordon J. Chelune,
  • Yana Suchy,
  • Elaine Clark,
  • Michael K. Cahalan,
  • Lowry Bushnell,
  • Derek Sakata,
  • Alan R. Light,
  • Kathleen C. Light
  • Article
  • Metrics
  • Comments
  • Media Coverage

The following information is missing from the Competing Interests section: At the time of the study, author DS had an equity interest in Anecare, a commercial company, which holds the license to the ANEclear device that was used in the study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.

Reference

  1. 1. Weeks HR III, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, et al. (2013) Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PLoS ONE 8(7): e69809. pmid:23922809

Citation: Weeks HR III, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, et al. (2017) Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PLoS ONE 12(4): e0175668. https://doi.org/10.1371/journal.pone.0175668

Published: April 6, 2017

Copyright: © 2017 Weeks et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.